Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexuprazan for Gastritis Symptoms in Patients on Systemic Steroids
NCT05946135Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Nov 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fexuprazan in gastritis, sponsored by Yonsei University. Started Nov 2023; status: completed.
02
Drugs
fexuprazan
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT05946135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05946135.